Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid

Adverse drug reactions are among the most frequent side effects of synthetic and complementary alternative drugs and represent the premier causes of license revocations and acute liver failure. Drug-induced liver injury can resemble literally any other genuine liver disease and usually responds well...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Jenny Sarah, Montani, Matteo, Stickel, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624238/
https://www.ncbi.nlm.nih.gov/pubmed/29033761
http://dx.doi.org/10.1159/000479314
_version_ 1783268215591272448
author Schneider, Jenny Sarah
Montani, Matteo
Stickel, Felix
author_facet Schneider, Jenny Sarah
Montani, Matteo
Stickel, Felix
author_sort Schneider, Jenny Sarah
collection PubMed
description Adverse drug reactions are among the most frequent side effects of synthetic and complementary alternative drugs and represent the premier causes of license revocations and acute liver failure. Drug-induced liver injury can resemble literally any other genuine liver disease and usually responds well to drug dechallenge. However, in some cases autoimmune-like hepatitis can evolve, requiring short- and sometimes long-term immunosuppression. Here, we present the hitherto first case of autoimmune-like hepatitis following treatment with zoledronic acid.
format Online
Article
Text
id pubmed-5624238
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-56242382017-10-13 Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid Schneider, Jenny Sarah Montani, Matteo Stickel, Felix Case Rep Gastroenterol Single Case Adverse drug reactions are among the most frequent side effects of synthetic and complementary alternative drugs and represent the premier causes of license revocations and acute liver failure. Drug-induced liver injury can resemble literally any other genuine liver disease and usually responds well to drug dechallenge. However, in some cases autoimmune-like hepatitis can evolve, requiring short- and sometimes long-term immunosuppression. Here, we present the hitherto first case of autoimmune-like hepatitis following treatment with zoledronic acid. S. Karger AG 2017-08-08 /pmc/articles/PMC5624238/ /pubmed/29033761 http://dx.doi.org/10.1159/000479314 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Schneider, Jenny Sarah
Montani, Matteo
Stickel, Felix
Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
title Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
title_full Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
title_fullStr Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
title_full_unstemmed Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
title_short Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
title_sort drug-induced autoimmune hepatitis following treatment with zoledronic acid
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624238/
https://www.ncbi.nlm.nih.gov/pubmed/29033761
http://dx.doi.org/10.1159/000479314
work_keys_str_mv AT schneiderjennysarah druginducedautoimmunehepatitisfollowingtreatmentwithzoledronicacid
AT montanimatteo druginducedautoimmunehepatitisfollowingtreatmentwithzoledronicacid
AT stickelfelix druginducedautoimmunehepatitisfollowingtreatmentwithzoledronicacid

Ejemplares similares